MENU
SNTI
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Senti Biosciences (SNTI) Ownership - Who owns Senti Biosciences?
Senti Biosciences Inc is a clinical-stage biotechnology company developing next-generation cell and gene therapies engineered with its gene circuit platform technologies for patients living with incurable diseases... Show more
Profile
Industry
N/A
Address
2 Corporate Drive
Phone
+1 650 239-2030
Employees
48
Web
https://www.sentibio.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
85.02M
P/E Ratio
8.81
Total Cash
48.28M
Projected Growth
N/A
Total Debt
33.64M
Revenue
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
1.85
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
SNTI
Capitalization
85M
P/E Ratio
8.81
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
48.3M
Total Cash/Share
1.85
Total Debt
33.6M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
25.6M
P/B Ratio
2.25
Cash Flow
N/A
Earnings
-12.03
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
1K
Current Ratio
4.49
Current Revenue Per Employee
2090.16
Dividends Per Share - Security
N/A
EBITDA
-54.88M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-48.58
Shares Held By Institutions
2.58M
Shares Outstanding - Current
26.1M
Total Liabilities
72.2M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-7.123
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
2 Corporate Drive
Phone
+1 650 239-2030
Employees
48
Web
https://www.sentibio.com